Related Experiment Video
Updated: Aug 19, 2026

High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
NIH pre-clinical screening program: overview and current status
Angelo Izzo1, Lise Brandt, Todd Lasco
1Department of Microbiology, Colorado State University, Immunology and Pathology, Mycobacterial Research Laboratories, 1682 Campus Delivery, Fort Collins 80523-1682, USA. angelo.izzo@colostate.edu
Abstract:
The increase in the number of cases of Mycobacterium tuberculosis around the world has lead to a greater need for a more efficacious vaccine than the currently used M. bovis BCG. Despite the relative success of this attenuated vaccine there are multiple examples where alternative strategies are desperately needed. In 1996, the National Institutes of Health published a request calling for applications to test newly developed vaccines against tuberculosis. The current screening program at Colorado State University has tested a wide range of novel vaccine candidates.
Related Concept Videos
Preclinical Development: Overview
Clinical Trials: Overview
Drug Discovery: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...